09:13 AM EDT, 06/03/2025 (MT Newswires) -- Health care stocks were mixed pre-bell Tuesday as the Health Care Select Sector SPDR Fund ( XLV ) was down 0.2% and the iShares Biotechnology ETF (IBB) was slightly higher recently.

Beam Therapeutics ( BEAM ) shares were advancing by more than 1% after the company said the US Food and Drug Administration has granted orphan drug designation to BEAM-101, an investigational cell therapy for sickle cell disease.

Amylyx Pharmaceuticals ( AMLX ) shares were up more than 5% after the company said its potential amyotrophic lateral sclerosis treatment AMX0114 has received the US Food and Drug Administration's fast-track designation.

Vera Therapeutics ( VERA ) shares were more than 1% higher after the company said it signed a new credit facility with Oxford Finance worth up to $500 million, replacing its previous $50 million agreement.